Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Stellate ganglion block reduces vasomotor symptom frequency by 4-90% in clinical trials, offering a potential non-hormonal option for women with severe symptoms refractory to conservative care.
Obstetrics & Gynecology August 26th 2024